As one of the leading health research institutes in Canada, Lawson has many stories to tell. Search through our Latest News to find out about important medical breakthroughs, major announcements and research publications, new clinical trials, industry partnerships, commercialization developments and more.
Our Events calendar includes a variety of research, industry and foundation listings You can also find out more about Lawson’s signature events:
For Diana Lemaire, her long-standing professional role collided with a personal journey when she was diagnosed with colon cancer in 2015.
Her career has focused on the areas of care, education, quality and evaluation in different departments of London’s health delivery and research community.
“I’ve always had a curiosity and interest in how we know what we are achieving and how we are performing and improving over time”
Peter Saracino is currently taking part in the SYNERGIC Trial led by Dr. Manuel Montero-Odasso. The study includes cognitive training and physical exercises with the hopes of delaying dementia.
Researchers in London, Ontario have been awarded $1.345 million over five years through the second phase of the Canadian Consortium on Neurodegeneration in Aging (CCNA), announced today as part of Canada’s first national dementia strategy. CCNA is a collaborative research program tackling the challenge of dementia and other neurodegenerative illnesses.
Two new interventional studies have been brought to London, focused on improving quality of life for patients with Alzheimer’s disease and their caregivers. Both hope to improve upon standard approaches to treating agitation, a core symptom of Alzheimer’s.
Agitation is a significant source of stress for patients and caregivers. It is complex and difficult to treat. Often, families do not know about this particular symptom of Alzheimer’s and are not properly trained on how to manage care while dealing with agitation.